ABC241220P95000
- 0.00
- 0.000.00%
undefined Newsroom
J.P. Morgan Reaffirms Their Buy Rating on AmerisourceBergen (ABC)
TD Cowen Adjusts Price Target on AmerisourceBergen to $215 From $205, Maintains Outperform Rating
AmerisourceBergen Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), Ultragenyx Pharmaceutical (RARE) and AmerisourceBergen (ABC)
Morgan Stanley Maintains Equal-Weight on AmerisourceBergen, Raises Price Target to $190
AmerisourceBergen Analyst Ratings
Bank of America Securities Reaffirms Their Buy Rating on AmerisourceBergen (ABC)
UBS Adjusts AmerisourceBergen Price Target to $225 From $200, Maintains Buy Rating
Mizuho Maintains Neutral on AmerisourceBergen, Raises Price Target to $192
Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), AmerisourceBergen (ABC) and Doximity (DOCS)
Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS), AmerisourceBergen (ABC) and Centene (CNC)
Bank of America Securities Remains a Buy on AmerisourceBergen (ABC)
Healthcare Solutions Trends And M&A Prospects: AmerisourceBergen Gets A Price Target Hike Amid Upside Scenarios
Credit Suisse Lifts AmerisourceBergen's Price Target to $199 From $197 After Above-Consensus Fiscal Q2 Results, Keeps Outperform Rating
Barclays Maintains Overweight on AmerisourceBergen, Raises Price Target to $190
Barclays Keeps Their Buy Rating on AmerisourceBergen (ABC)
Analysts Offer Insights on Healthcare Companies: AmerisourceBergen (ABC), Biogen (BIIB) and Elevance Health (ELV)
Analysts Are Bullish on These Healthcare Stocks: AmerisourceBergen (ABC), Eli Lilly & Co (LLY)
The Latest Analyst Ratings for AmerisourceBergen
Baird Adjusts Price Target on AmerisourceBergen (Holding Co) to $201 From $199, Maintains Outperform Rating